Back to 
Carlyle Group Inc.
Carlyle Group Inc.
PCVX
Showing 0 of 2 quarters
Position history for Carlyle Group Inc.'s holdings in Vaxcyte, Inc.
No. Carlyle Group exited its PCVX (Vaxcyte) position in Q2 2023. Its Q1 2023 13F listed 1,923,158 shares worth $72.1M. Carlyle Group first reported PCVX in Q1 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.